D-cycloserine: A Novel Treatment for Gulf War Illness (GWDCS)

NCT02983734 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Gulf War Illness

Interventions

DRUG: D-cycloserine
DRUG: Placebos

Sponsor

Boston University Charles River Campus